Literature DB >> 8392601

Functional domains of the simian foamy virus type 1 transcriptional transactivator (Taf).

A Mergia1, L W Renshaw-Gegg, M W Stout, R Renne, O Herchenröeder.   

Abstract

The genome of simian foamy virus type 1 encodes a transcriptional transactivator (Taf) that dramatically elevates gene expression directed by the viral long terminal repeat. In this report, we describe the functional domains of simian foamy virus type 1 Taf. Several taf mutants and fusion proteins of Taf and the DNA-binding domain of the Saccharomyces cerevisiae transcriptional transactivator GAL4 were used in this study. Taf contains two potent activation domains. One of the activation domains is located at the amino terminus (positions 1 to 48, with position 1 representing the initiator amino acid methionine) and contains several acidic amino acids. The second activation domain was mapped to a region at the carboxy terminus (positions 277 to 300). These two domains activate gene expression directed by the viral long terminal repeat independently of each other. No significant amino acid sequence homology between the activation domains is noted. Thus, Taf belongs in part to the family of acidic transcriptional transactivators. The activation domain at the carboxy terminus is conserved among foamy virus transactivators but is not related to other known transcriptional activators. Therefore, the mechanism of gene activation by the carboxy terminus of Taf may be novel. In addition, a potential binding domain rich in basic amino acids (positions 179 to 222) and a highly conserved sequence among foamy virus transactivators (positions 93 to 109) were found to be critical for Taf activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392601      PMCID: PMC237844     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Mutants of GAL4 protein altered in an activation function.

Authors:  G Gill; M Ptashne
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

2.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

3.  Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion proteins.

Authors:  P J Godowski; D Picard; K R Yamamoto
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

Review 4.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

5.  Negative effect of the transcriptional activator GAL4.

Authors:  G Gill; M Ptashne
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

6.  Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit.

Authors:  E Giniger; M Ptashne
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

Review 7.  Human foamy virus: an underestimated neuropathogen?

Authors:  A Aguzzi; K Bothe; E F Wagner; A Rethwilm; I Horak
Journal:  Brain Pathol       Date:  1992-01       Impact factor: 6.508

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus.

Authors:  B Maurer; H Bannert; G Darai; R M Flügel
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

10.  Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes.

Authors:  R M Flügel; A Rethwilm; B Maurer; G Darai
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  12 in total

1.  Transcriptional mapping of the 3' end of the bovine syncytial virus genome.

Authors:  R W Renshaw; J W Casey
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

2.  Characterization of the internal promoter of simian foamy viruses.

Authors:  M Campbell; L Renshaw-Gegg; R Renne; P A Luciw
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

3.  Deletion analysis of both the long terminal repeat and the internal promoters of the human foamy virus.

Authors:  P Yang; M Zemba; M Aboud; R M Flügel; M Löchelt
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter.

Authors:  Y Kang; W S Blair; B R Cullen
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Characterization of provirus clones of simian foamy virus type 1.

Authors:  A Mergia; M Wu
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Genetic analysis indicates that the human foamy virus Bel-1 protein contains a transcription activation domain of the acidic class.

Authors:  W S Blair; H Bogerd; B R Cullen
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.

Authors:  L M Carruth; J M Hardwick; B A Morse; J E Clements
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter.

Authors:  J X Zou; P A Luciw
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  The Bel1 protein of human foamy virus contains one positive and two negative control regions which regulate a distinct activation domain of 30 amino acids.

Authors:  C W Lee; J Chang; K J Lee; Y C Sung
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Nucleotide sequence and protein analysis of a complex piscine retrovirus, walleye dermal sarcoma virus.

Authors:  D L Holzschu; D Martineau; S K Fodor; V M Vogt; P R Bowser; J W Casey
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.